Fierce Pharma17h
Canada's Entos Pharmaceuticals plots $137M R&D, manufacturing hub in Edmonton
With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...
Investing News Network on MSN10h
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines
Life science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an ...
Hemophilia Market Size to Hit USD 24.2 Billion by 2032, Driven by Advancements in Gene Therapy and Innovative Treatment Solutions – SNS Insider
Rising Prevalence of Hemophilia, Increasing Adoption of Recombinant Therapies, and Breakthroughs in Gene Therapy Propel Market Growth.Pune, March 12, 2025 (GLOBE NEWSWIRE) -- Hemophilia Market Size & ...
Taiwan News11h
Global Hemophilia Treatment Market to Reach USD 21.48 Billion by 2033, Driven by Advanced Therapies and Innovative Solutions
Market Valuation Set to Surge from USD 13.23 Billion in 2024 at a CAGR of 5.69% ...
Indiatimes10h
Sanofi India Share Price
Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 12,624.35 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...